Top News: Cleveland BioLabs, Inc. (NASDAQ:CBLI), Mast Therapeutics, Inc. (NYSEMKT:MSTX), Nuveen California Dividend Advantage Municipal Fund 3 (NYSEMKT:NZH),

On 22 February, Cleveland BioLabs Inc. (NASDAQ:CBLI) reported a net loss, excluding minority interests, of $(1.4) million for the fourth quarter of 2015, or $(0.13) per share, compared to net income of $11.3 million, or $3.95 per share, for the fourth quarter of 2014. Net loss, excluding minority interests, for full year 2015 was $(12.6) million, or $(1.79) per share, compared to a net income of $1.6 million, or $0.60 per share, for full year 2014. The 2014 periods reported net income due to a $14.2 million gain on the deconsolidation of the Company’s joint venture, Incuron LLC. Excluding the gain on the deconsolidation of Incuron, net loss per share for the fourth quarter of 2014 was $(1.02) and net loss per share for full year 2014 was $(4.66).

Cleveland BioLabs, Inc. (NASDAQ:CBLI) belongs to Healthcare sector. Its weekly performance is -7.67%. On last trading day company shares ended up at $3.25.

Mast Therapeutics, Inc. (NYSE MKT: MSTX), announced that it has entered into an amendment to its existing $15 million debt facility with Hercules Capital, Inc. (HTGC).

Mast Therapeutics, Inc. (NYSEMKT:MSTX) shares moved up 2.30% in last trading session and ended the day at $0.29. MSTX return on assets is -58.40%. Mast Therapeutics, Inc. (NYSEMKT:MSTX) quarterly performance is -31.19%.

On 29 February, Nuveen California Dividend Advantage Municipal Fund 3 (NYSEMKT:NZH) shares moved up 0.55% and was closed at $14.56. Nuveen California Dividend Advantage Municipal Fund 3 (NYSEMKT:NZH) year to date (YTD) performance is 3.86%.

CenturyLink, Inc. (NYSE:CTL) announced that its Board of Directors voted to declare a regular quarterly cash dividend of $0.54 per share, which will be payable on March 18, 2016, to shareholders of record on March 4, 2016.

CenturyLink, Inc. (NYSE:CTL) ended the last trading day at $30.59. Company weekly volatility is calculated as 2.92% and price to cash ratio as 132.03. CenturyLink, Inc. (NYSE:CTL) showed a weekly performance of 2.00%.

On 25 February, Sabre Corporation (NASDAQ:SABR) announced the secondary public offering of 20,000,000 shares of common stock by existing stockholders affiliated with TPG Global, LLC and Silver Lake Management Company II, L.L.C. (the “Selling Stockholders”). All of the shares are being sold on a pro rata basis by the Selling Stockholders in accordance with their current interests, and the Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by the Company.

Sabre Corporation (NASDAQ:SABR) shares fell -0.29% in last trading session and ended the day at $27.15. SABR Gross Margin is 34.30% and its return on assets is 10.50%. Sabre Corporation (NASDAQ:SABR) quarterly performance is -7.62%.

Leave a Reply

Your email address will not be published. Required fields are marked *